845439-90-9

Upstream product

• 845439-02-3 dimethyl-thiocarbamic acid O-(4-benzyloxy-2'-diethylcarbamoyl-4'-methoxy-biphenyl-2-yl) ester 
• 845439-13-6 dimethyl-thiocarbamic acid S-(4-benzyloxy-2'-diethylcarbamoyl-4'-methoxy-biphenyl-2-yl) ester 
• 845438-93-9 4'-benzyloxy-2'-hydroxy-4-methoxy-biphenyl-2-carboxylic acid diethylamide 
• 845439-45-4 2-hydroxy-7-triisopropylsilanyloxy-9-thia-phenanthren-10-one 
• 845439-35-2 2-methoxy-7-triisopropylsilanyloxy-9-thia-phenanthren-10-one 
• 845439-54-5 7-triisopropylsilanyloxy-10H-9-thia-phenanthren-2-ol 
• 845438-83-7 3-(Benzyloxy)-8-methoxy-6H-benzo[c]chromen-6-one 
• 845439-23-8 7-benzyloxy-2-methoxy-9-thia-phenanthren-10-one 
• 108-46-3 recorcinol 
• 13154-24-0 triisopropylsilyl chloride 
• 26116-47-2 4-(2-tetrahydro-1H-1-pyrrolylethoxy)benzaldehyde 
• 845439-63-6 2-(tert-butyl-dimethyl-silanyloxy)-7-triisopropylsilanyloxy-10H-9-thia-phenanthrene 

Relevant academic research and scientific papers

Estrogen receptor ligands. 12. Synthesis of the major metabolites of an ERα-selective, dihydrobenzoxathiin antagonist for osteoporosis

(Chemical Equation Presented) During the course of drug metabolism studies, a major metabolite of compound 1 was detected in rhesus monkeys and assigned structure 4. The intriguing biotransformation of 1 leading to 4 was confirmed by a 19-step total synth